Ronnie T. P. Poon

14.9k total citations · 5 hit papers
137 papers, 10.2k citations indexed

About

Ronnie T. P. Poon is a scholar working on Hepatology, Surgery and Epidemiology. According to data from OpenAlex, Ronnie T. P. Poon has authored 137 papers receiving a total of 10.2k indexed citations (citations by other indexed papers that have themselves been cited), including 80 papers in Hepatology, 55 papers in Surgery and 39 papers in Epidemiology. Recurrent topics in Ronnie T. P. Poon's work include Hepatocellular Carcinoma Treatment and Prognosis (74 papers), Liver Disease Diagnosis and Treatment (31 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (29 papers). Ronnie T. P. Poon is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (74 papers), Liver Disease Diagnosis and Treatment (31 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (29 papers). Ronnie T. P. Poon collaborates with scholars based in Hong Kong, China and United States. Ronnie T. P. Poon's co-authors include Sheung Tat Fan, Chung Mau Lo, John M. Luk, Kelvin K. Ng, Roberta Pang, Wan Yu, Thomas Yau, Chun Yeung, David Ho and Chi‐Ming Lam and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and Gastroenterology.

In The Last Decade

Ronnie T. P. Poon

136 papers receiving 10.0k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Significance of CD90+ Cancer Stem Cells in Human Liver Cancer

2008 963 citations Ronnie T. P. Poon, Sheung Tat Fan et al. profile →
Ramucirumab versus placebo as second-line treatment in patients with advanced hepatocellular carcinoma following first-line therapy with sorafenib (REACH): a randomised, double-blind, multicentre, phase 3 trial

2015 634 citations Ronnie T. P. Poon et al. profile →
Improving Perioperative Outcome Expands the Role of Hepatectomy in Management of Benign and Malignant Hepatobiliary Diseases

2004 546 citations Ronnie T. P. Poon, Sheung Tat Fan et al. Annals of Surgery profile →
Development of Hong Kong Liver Cancer Staging System With Treatment Stratification for Patients With Hepatocellular Carcinoma

2014 495 citations Thomas Yau, Vikki Tang et al. Gastroenterology profile →
A Subpopulation of CD26+ Cancer Stem Cells with Metastatic Capacity in Human Colorectal Cancer

2010 438 citations Andrew Chu, Ariel Ka-Man Chow et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ronnie T. P. Poon Hong Kong	54	4.5k	3.5k	3.0k	3.0k	2.3k	137	10.2k
Sasan Roayaie United States	40	6.4k 1.4×	2.7k 0.8×	3.0k 1.0×	3.2k 1.1×	3.6k 1.6×	88	12.0k
Mengchao Wu China	59	5.2k 1.2×	3.7k 1.1×	4.8k 1.6×	3.5k 1.2×	3.3k 1.4×	312	13.7k
Shigeki Arii Japan	60	6.5k 1.5×	3.4k 1.0×	5.4k 1.8×	3.3k 1.1×	3.7k 1.6×	307	14.4k
Massimo Roncalli Italy	59	2.7k 0.6×	4.7k 1.3×	3.2k 1.1×	1.8k 0.6×	2.1k 0.9×	228	11.5k
Ronnie Tung‐Ping Poon Hong Kong	46	7.4k 1.7×	2.3k 0.7×	2.1k 0.7×	3.4k 1.2×	3.7k 1.6×	78	11.0k
Tim Meyer United Kingdom	55	6.7k 1.5×	4.9k 1.4×	2.6k 0.9×	2.2k 0.7×	4.2k 1.8×	237	13.8k
Chung Mau Lo Hong Kong	65	8.5k 1.9×	3.3k 0.9×	3.1k 1.0×	6.6k 2.2×	4.4k 1.9×	341	15.0k
Zhao–You Tang China	63	5.2k 1.2×	4.1k 1.2×	6.5k 2.2×	1.8k 0.6×	2.8k 1.2×	209	14.8k
Daniel H. Palmer United Kingdom	39	3.3k 0.8×	5.3k 1.5×	2.4k 0.8×	4.7k 1.6×	2.4k 1.1×	219	11.7k
Iwao Ikai Japan	54	6.6k 1.5×	2.1k 0.6×	1.7k 0.6×	4.1k 1.4×	3.5k 1.5×	221	10.3k

Countries citing papers authored by Ronnie T. P. Poon

Since Specialization

Citations

This map shows the geographic impact of Ronnie T. P. Poon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ronnie T. P. Poon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ronnie T. P. Poon more than expected).

Fields of papers citing papers by Ronnie T. P. Poon

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ronnie T. P. Poon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ronnie T. P. Poon. The network helps show where Ronnie T. P. Poon may publish in the future.

Co-authorship network of co-authors of Ronnie T. P. Poon

This figure shows the co-authorship network connecting the top 25 collaborators of Ronnie T. P. Poon. A scholar is included among the top collaborators of Ronnie T. P. Poon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ronnie T. P. Poon. Ronnie T. P. Poon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ho, Daniel Wai‐Hung, Lo‐Kong Chan, Mingjing Xu, et al.. (2016). TSC1/2 mutations define a molecular subset of HCC with aggressive behaviour and treatment implication. Gut. 66(8). 1496–1506. 87 indexed citations

Chow, Ariel Ka-Man, Thomas Yau, Lui Ng, et al.. (2015). A preclinical study on the combination therapy of everolimus and transarterial chemoembolization in hepatocellular carcinoma.. PubMed Central. 5(8). 2376–86. 7 indexed citations

Lim, Ho Yeong, Jeong Heo, Hye Jin Choi, et al.. (2014). A Phase II Study of the Efficacy and Safety of the Combination Therapy of the MEK Inhibitor Refametinib (BAY 86-9766) Plus Sorafenib for Asian Patients with Unresectable Hepatocellular Carcinoma. Clinical Cancer Research. 20(23). 5976–5985. 86 indexed citations

Dai, Wing Chiu, See Ching Chan, Ksh Chok, et al.. (2014). Good longterm survival after primary living donor liver transplantation for solitary hepatocellular carcinomas up to 8 cm in diameter. HPB. 16(8). 749–757. 14 indexed citations

Wong, Tiffany, Tan To Cheung, Ksh Chok, et al.. (2014). Outcomes of hepatectomy for hepatocellular carcinoma with bile duct tumour thrombus. HPB. 17(5). 401–408. 28 indexed citations

Yau, Thomas, et al.. (2014). Development of Hong Kong Liver Cancer Staging System With Treatment Stratification for Patients With Hepatocellular Carcinoma. Gastroenterology. 146(7). 1691–1700.e3. 495 indexed citations breakdown →

Chan, Albert, Tan To Cheung, Sheung Tat Fan, et al.. (2013). Survival Analysis of High-Intensity Focused Ultrasound Therapy Versus Radiofrequency Ablation in the Treatment of Recurrent Hepatocellular Carcinoma. Annals of Surgery. 257(4). 686–692. 55 indexed citations

Liu, Angela M., Tzy‐Jyun Yao, Wei Wang, et al.. (2012). Circulating miR-15b and miR-130b in serum as potential markers for detecting hepatocellular carcinoma: a retrospective cohort study. BMJ Open. 2(2). e000825–e000825. 192 indexed citations

Gallagher, Tom, Albert Chan, Ronnie T. P. Poon, et al.. (2012). Outcomes of central bisectionectomy for hepatocellular carcinoma. HPB. 15(7). 529–534. 11 indexed citations

10.

Cheung, Tan To, Ksh Chok, Regina Cheuk‐Lam Lo, et al.. (2012). High-intensity focused ultrasound ablation as a bridging therapy for hepatocellular carcinoma patients awaiting liver transplantation. Hepatobiliary & pancreatic diseases international. 11(5). 542–544. 9 indexed citations

11.

Sun, Stella, Zhi Xu, Ronnie T. P. Poon, Philip J. Day, & John M. Luk. (2009). Circulating Lamin B1 (LMNB1) Biomarker Detects Early Stages of Liver Cancer in Patients. Journal of Proteome Research. 9(1). 70–78. 112 indexed citations

12.

Poon, Ronnie T. P. & Sheung Tat Fan. (2008). Decreasing the Pancreatic Leak Rate After Pancreaticoduodenectomy. Advances in Surgery. 42. 33–48. 20 indexed citations

13.

Mazzaferro, Vincenzo, Yun Shin Chun, Ronnie T. P. Poon, et al.. (2008). Liver Transplantation for Hepatocellular Carcinoma. Annals of Surgical Oncology. 15(4). 1001–1007. 237 indexed citations

14.

Yang, Zhenfan, et al.. (2007). Blockade of chemokine receptor CXCR4 for the treatment of hepatocellular carcinoma metastasis. Molecular Cancer Therapeutics. 6. 2 indexed citations

15.

Poon, Ronnie T. P.. (2007). Current techniques of liver transection. HPB. 9(3). 166–173. 84 indexed citations

16.

Chen, Minhua, Wei Yang, Kun Yan, et al.. (2006). Treatment Strategy to Optimize Radiofrequency Ablation for Liver Malignancies. Journal of Vascular and Interventional Radiology. 17(4). 671–683. 59 indexed citations

17.

Poon, Ronnie T. P.. (2006). Optimal Initial Treatment for Early Hepatocellular Carcinoma in Patients with Preserved Liver Function: Transplantation or Resection?. Annals of Surgical Oncology. 14(2). 541–547. 46 indexed citations

18.

Tang, Terence, et al.. (2005). Celecoxib suppresses the HCC development via the cell cycle arrest. Cancer Research. 65. 709–710. 2 indexed citations

19.

Liu, Chi Leung, Sheung Tat Fan, Chung Mau Lo, et al.. (2005). Comparison of Early Endoscopic Ultrasonography and Endoscopic Retrograde Cholangiopancreatography in the Management of Acute Biliary Pancreatitis: A Prospective Randomized Study. Clinical Gastroenterology and Hepatology. 3(12). 1238–1244. 71 indexed citations

20.

Poon, Ronnie T. P., Sheung Tat Fan, Chung Mau Lo, et al.. (2004). Improving Perioperative Outcome Expands the Role of Hepatectomy in Management of Benign and Malignant Hepatobiliary Diseases. Annals of Surgery. 240(4). 698–710. 546 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact